- Home
- NRIX vs WTTR Comparison
NRIX vs WTTR Comparison
Compare NRIX & WTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIX
- WTTR
- Stock Information
- Founded
- NRIX 2009
- WTTR 2016
- Country
- NRIX United States
- WTTR United States
- Employees
- NRIX N/A
- WTTR N/A
- Industry
- NRIX Biotechnology: Pharmaceutical Preparations
- WTTR Oilfield Services/Equipment
- Sector
- NRIX Health Care
- WTTR Energy
- Exchange
- NRIX Nasdaq
- WTTR Nasdaq
- Market Cap
- NRIX 908.0M
- WTTR 922.1M
- IPO Year
- NRIX 2020
- WTTR 2017
- Fundamental
- Price
- NRIX $11.64
- WTTR $8.78
- Analyst Decision
- NRIX Strong Buy
- WTTR Strong Buy
- Analyst Count
- NRIX 16
- WTTR 3
- Target Price
- NRIX $30.44
- WTTR $14.83
- AVG Volume (30 Days)
- NRIX 857.7K
- WTTR 841.2K
- Earning Date
- NRIX 07-10-2025
- WTTR 07-29-2025
- Dividend Yield
- NRIX N/A
- WTTR 3.20%
- EPS Growth
- NRIX N/A
- WTTR N/A
- EPS
- NRIX N/A
- WTTR 0.34
- Revenue
- NRIX $56,417,000.00
- WTTR $1,459,911,000.00
- Revenue This Year
- NRIX $16.69
- WTTR $2.68
- Revenue Next Year
- NRIX N/A
- WTTR $5.03
- P/E Ratio
- NRIX N/A
- WTTR $25.40
- Revenue Growth
- NRIX N/A
- WTTR N/A
- 52 Week Low
- NRIX $8.18
- WTTR $7.20
- 52 Week High
- NRIX $29.56
- WTTR $15.14
- Technical
- Relative Strength Index (RSI)
- NRIX 54.44
- WTTR 49.35
- Support Level
- NRIX $11.17
- WTTR $8.56
- Resistance Level
- NRIX $11.99
- WTTR $9.53
- Average True Range (ATR)
- NRIX 0.58
- WTTR 0.29
- MACD
- NRIX -0.07
- WTTR -0.04
- Stochastic Oscillator
- NRIX 37.50
- WTTR 23.08
About NRIX Nurix Therapeutics Inc. Common stock
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.